Announcements Trials
Browse Landscape

Phase

Phase NA 27Phase 3 5Phase 2 4Phase EARLY_PHASE1 1Phase 1 1

Status

Withdrawn 1Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4

Conditions

Neoplasms 8Neoplasm Metastasis 8Carcinoma, Non-Small-Cell Lung 8Breast Neoplasms 8Colorectal Neoplasms 7Prostatic Neoplasms 6Urinary Bladder Neoplasms 5Leukemia, Myeloid, Acute 5Squamous Cell Carcinoma of Head and Neck 4Ovarian Neoplasms 4Lung Neoplasms 4Glioblastoma 4Triple Negative Breast Neoplasms 3Mouth Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Transitional Cell 3Carcinoma, Ovarian Epithelial 3Uterine Cervical Neoplasms 2Ureteral Neoplasms 2Stomatitis 2Recurrence 2Oropharyngeal Neoplasms 2Melanoma 2Laryngeal Neoplasms 2Gastrointestinal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma 2COVID-19 2Brain Neoplasms 2Adenocarcinoma 2

Interventions

Carboplatin 195Cisplatin 117Paclitaxel 107Pemetrexed 106Docetaxel 96Gemcitabine 89Radiotherapy 83Erlotinib Hydrochloride 58Bevacizumab 55Etoposide 49durvalumab 39pembrolizumab 38Nivolumab 31Specimen Handling 30Magnetic Resonance Spectroscopy 30Irinotecan 27Radiosurgery 26osimertinib 24Gefitinib 24Drug Therapy 23Vinorelbine 22atezolizumab 20Topotecan 20Radiation 16Cetuximab 16Taxes 15Surgical Procedures, Operative 14Neoadjuvant Therapy 13Filgrastim 13Chemotherapy, Adjuvant 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Lung Neoplasms × Standard of Care × Clear all
NCT04067830 2026-05-18

Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer

Roswell Park Cancer Institute

Phase 2 Recruiting
220 enrolled
Thoracic

Lung Neoplasms

NCT04602533 2026-02-27

Efficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease Small Cell Lung Cancer (DOLPHIN)

Johannes Gutenberg University Mainz

Phase 2 Active not recruiting
105 enrolled
Thoracic

Lung Neoplasms

NCT03628144 2020-09-10

Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03472053 2020-05-19

A Study of BIO-11006 in the Treatment of Advanced Non-Small Cell Lung Cancer

BioMarck Pharmaceuticals, Ltd.

Phase 2 Completed
60 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡